Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure

Journal of Cardiovascular Medicine

Volumn 14, Issue 6, 2013, Pages 438-445

  Harskamp, Ralf E ^a   Beijk, Marcel A ^a   Damman, Peter ^a   Kuijt, Wichert J ^a   Woudstra, Pier ^a   Grundeken, Maik J ^a   Kloek, Jaap J ^a   Tijssen, Jan G ^a   De Mol, Bas A ^a   De Winter, Robbert J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Bypass graft; Graft failure; Outcome; Percutaneous coronary intervention; Redo coronary artery bypass graft

Indexed keywords

CREATINE KINASE MB; CREATININE;

AGED; ARTICLE; BARE METAL STENT; CALCULATION; CAUSE OF DEATH; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; CREATININE BLOOD LEVEL; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GRAFT FAILURE; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VEIN GRAFT DISEASE;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METALS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; TRIAGE;

EID: 84879499673     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328356a4fc     Document Type: Article

References (32)

1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton Jr. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996; 28:616-626. (Pubitemid 26288642)
2. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001; 38:150-154. (Pubitemid 32613842)
3. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol 2002; 40:1951-1954. (Pubitemid 35425365)
4. Sabik JF III, Blackstone EH, Houghtaling PL, Walts PA, Lytle BW. Is reoperation still a risk factor in coronary artery bypass surgery? Ann Thorac Surg 2005; 80:1719-1727. (Pubitemid 41464290)
5. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004; 109:2290-2295. (Pubitemid 38678519)
6. Hamada Y, Kawachi K, Yamamoto T, et al. Effect of coronary artery bypass grafting on native coronary artery stenosis. Comparison of internal thoracic artery and saphenous vein grafts. J Cardiovasc Surg (Torino) 2001; 42:159-164. (Pubitemid 32451648)
7. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 20:2501-2555.
8. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, Paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350:221-231. (Pubitemid 38067635)
9. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323. (Pubitemid 37186209)
10. Stettler C, Wandel C, Allemann S, et al. Outcomes associated with drugeluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 15:937-948. (Pubitemid 47393576)
11. Kirtane AJ, Gupta A, Iyengar S. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119:3198-3206.
12. Brilakis ES, Lichtenwalter C, de Lemos JA, et al. A randomized controlled trial of a paclitaxel-eluting stent versus a similar baremetal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol 2009; 53:919-928.
13. Vermeersch P, Agostoni P, Verheye S, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 2006; 48:2423-2431. (Pubitemid 44895571)
14. Jeger RV, Schneiter S, Kaiser C, et al. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions. Cardiology 2009; 112:49-55.
15. Meier P, Brilakis ES, Corti R, Knapp G, Shishehbor MH, Gurm HS. Drugeluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis. PLoS One 2010; 10:e11040.
16. Brilakis ES, Lichtenwalter C, Abdel-karim AR, et al. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) Trial. JACC Cardiovasc Interventions 2011; 4:176-182.
17. Wiisanen ME, Abdel-Latif A, Mukherjee D, Ziada KM. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions. J Am Coll Cardiol Intv 2010; 3:1262-1273.
18. Testa L, Agostoni P, Vermeersch P, et al. Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis. Euro Intervention 2010; 6:527-536.
19. Parang P, Arora R. Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 2009; 25:e57-e62.
20. Davies MG, Hagen PO. Pathophysiology of vein graft failure. Eur J Vasc Endovasc Surg 1995; 9:7-18.
21. Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery. J Am Coll Cardiol 2004; 44:2149-2156.
22. Brody WR, Kosek JC, Angell WW. Changes in vein grafts following aortocoronary bypass induced by pressure and ischemia. J Thorac Cardiovasc Surg 1972; 64:847-854.
23. Bulkley BH, Hutchins GM. Accelerated 'atherosclerosis'. A morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation 1977; 55:163-169. (Pubitemid 8015608)
24. Nillson J, Algotsson L, Höglund P, Lührs C, Brandt J. Comparison of 19 preoperative risk stratification models in open heart surgery. Eur Heart J 2006; 27:867-874.
25. Romagnoli E, Burzotta F, Trani C, et al. EuroSCORE as predictor of inhospital mortality after percutaneous coronary intervention. Heart 2009; 95:43-48.
26. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115:2344-2351. (Pubitemid 46685903)
27. Abdel-Karim AR, Banerjee S, Brilakis ES, et al. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes. J Invasive Cardiol 2010; 22:253-257.
28. Halabi AR, Alexander JH, Shaw JK, et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 2005; 96:1254-1259. (Pubitemid 41505404)
29. Mehilli J, Pache J, Abdel-Wahab M, et al. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. Lancet 2011; 378:1071-1078.
30. Borowski A, Vchivkov I, Ghodsizad A, Gams E. Coronary artery disease progression in patients who need repeat surgical revascularisation: the surgeon's point of view. J Cardiovasc Med (Hagerstown) 2008; 9:85-88. (Pubitemid 351339914)
31. Rupprecht HJ, Hamm C, Ischinger T, et al. Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial). GABI Study Group. Eur Heart J 1996; 17:1192-1198. (Pubitemid 26289952)
32. Manninen HI, Jaakkola P, Suhonen M, et al. Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts. Ann Thorac Surg 1998; 66:1289-1294. (Pubitemid 28518066)